Literature DB >> 1439843

Primary Sjögren's syndrome--clinical and laboratory markers of disease activity.

P Oxholm1.   

Abstract

Primary Sjögren's syndrome is a chronic autoimmune disorder of the lacrimal and salivary glands, reflecting general involvement of the exocrine tissues and leading to functional impairment. This polyglandular disease is often associated with systemic extraglandular manifestations, and laboratory tests usually indicate polyclonal B-lymphocyte hyperactivity. Clinical and laboratory markers monitoring the disease processes are needed for improved management of primary Sjögren's syndrome. However, incomplete knowledge of the long-term course of inflammation as well as of clinical manifestations makes precise and simple directions for monitoring disease activity in primary Sjögren's syndrome difficult. This review describes potential primary (eg, salivary gland histopathology, autoantibodies, soluble interleukin-2 receptors, and beta 2-microglobulin) and secondary disease activity markers (clinical and laboratory signs of glandular and extraglandular organ damage) and their known associations. The importance of genetic characteristics, patient age, and symptom duration for the disease activity markers is indicated. The systematic use of primary and secondary disease activity markers will improve our understanding of primary Sjögren's syndrome and help create better guidelines for monitoring the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439843     DOI: 10.1016/0049-0172(92)90005-x

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  6 in total

1.  Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; M Wahren-Herlenius; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome.

Authors:  Eugene Park; Hae-Rim Kim; Hee Joung Kim; Sang-Heon Lee
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

3.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Authors:  Mohamed L Sorror; Paul J Martin; Rainer F Storb; Smita Bhatia; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Christopher Davis; H Joachim Deeg; Stephanie J Lee; David G Maloney; Brenda M Sandmaier; Frederick R Appelbaum; Theodore A Gooley
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

4.  Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.

Authors:  J-E Gottenberg; M Busson; J Cohen-Solal; F Lavie; K Abbed; R P Kimberly; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

5.  An unusual clinical manifestation of secondary Sjögren's syndrome and concomitant Paterson-Kelly syndrome.

Authors:  H Dejmkova; K Pavelka
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

Review 6.  Classification of disease manifestations in primary Sjögren's syndrome: present status and a new proposal.

Authors:  P Oxholm; K Asmussen
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.